J0878Daptomycin injection
Published CMS Medicare Part B payment-limit context for J0878, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$0.029
per 1 MG · Medicare Part B
Down 14.7%from $0.034 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$0.036$0.027
2024-Q4: $0.032; 2025-Q1: $0.035; 2025-Q2: $0.033; 2025-Q3: $0.03; 2025-Q4: $0.028; 2026-Q1: $0.028; 2026-Q2: $0.034; 2026-Q3: $0.029
No current FDA shortage matchThe latest completed FDA data has no affected record matching the Daptomycin ingredient family (FDA data as of August 20, 2026).
Daptomycin
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Other Daptomycin presentations
4 other CMS codesSource-linked same ingredient-family context, not recommendations, substitutes, or clinical or billing equivalence.
Swipe to see all columns
| HCPCS | CMS description | Current quarter 2026-Q3 | Prior quarter 2026-Q2 | Change | NDCs | View history |
|---|---|---|---|---|---|---|
| J0872 | Daptomycin (xellia) unrefrig | $0.042 per 1 MG | $0.054 per 1 MG | Down 22.2% | ||
| J0873 | Inj daptomycin (xellia) | $0.045 per 1 MG | $0.026 per 1 MG | Up 73.1% | ||
| J0874 | Inj, daptomycin (baxter) | $0.06 per 1 MG | $0.057 per 1 MG | Up 5.3% | ||
| J0877 | Inj, daptomycin (hospira) | $0.057 per 1 MG | $0.054 per 1 MG | Up 5.6% |
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.